Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to
assemble and peer-review its pathway modules. The integration of ORCID within Reactome
enables us to meet a key challenge with authoring, curating and reviewing biological
information by incentivizing and crediting the external experts that contribute their
expertise and time to the Reactome curation process. More information is available at
ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please
forward this information to us and we will update your Reactome pathway records.
Details on Person Factor VIII (FVIII) circulates in plasma as a heterodimer (d...
| Class:Id | Summation:9670020 |
| _displayName | Factor VIII (FVIII) circulates in plasma as a heterodimer (d... |
| _timestamp | 2019-12-04 03:00:00 |
| created | [InstanceEdit:9670022] Shamovsky, Veronica, 2019-12-04 |
| literatureReference | [LiteratureReference:9661682] Biosynthesis, assembly and secretion of coagulation factor VIII [LiteratureReference:9670024] Characterization of the interaction between the A2 subunit and A1/A3-C1-C2 dimer in human factor VIIIa [LiteratureReference:5607045] Human factor VIIIa subunit structure. Reconstruction of factor VIIIa from the isolated A1/A3-C1-C2 dimer and A2 subunit [LiteratureReference:9670009] Factor VIII structure and function [LiteratureReference:9670015] Contribution of A1 subunit residue Q316 in thrombin-activated factor VIII to A2 subunit dissociation [LiteratureReference:9670016] A1 subunit-mediated regulation of thrombin-activated factor VIII A2 subunit dissociation [LiteratureReference:9670011] Identification of residues contributing to A2 domain-dependent structural stability in factor VIII and factor VIIIa [LiteratureReference:9670018] Generation of enhanced stability factor VIII variants by replacement of charged residues at the A2 domain interface [LiteratureReference:9670012] Stabilizing interactions between D666-S1787 and T657-Y1792 at the A2-A3 interface support factor VIIIa stability in the blood clotting pathway [LiteratureReference:9670010] Modification of interdomain interfaces within the A3C1C2 subunit of factor VIII affects its stability and activity |
| text | Factor VIII (FVIII) circulates in plasma as a heterodimer (domain structure A1-A2-B:A3-C1-C2) that requires thrombin cleavage to elicit procoagulant activity (Kaufman RJ et al. 1997). Upon activation by thrombin FVIII is converted to the labile FVIIIa, a heterotrimer of A1, A2 and A3C1C2 subunits, which serves as a cofactor for FIXa (Fay PJ 2006). At physiological concentrations, FVIIIa decays as a result of A2 subunit dissociation, which is weakly associated with the A1:A3-C1-C2 dimer by primarily electrostatic interactions (Fay PJet al. 1991; Fay PJ & Smudzin TM 1992; Parker ET et al 2006). Site-directed mutagenesis, functional and structural studies suggest that multiple residues at the A1-A2 and A2-A3 domain interfaces contribute to non-covalent interactions in stabilizing the protein (Parker ET & Lollar P 2007; Wakabayashi H & Fay PJ 2008, 2013; Wakabayashi H et al. 2008; Monaghan M et al. 2016). Retention of A2 polypeptide is required for normal stability of FVIIIa and dissociation of A2 correlates with FVIIIa inactivation and consequent loss of FXase activity. |
| (summation) | [Reaction:9670014] Factor VIIIa dissociates [Homo sapiens] |
|
[Change default viewing format]
|
No pathways have been reviewed or authored by Factor VIII (FVIII) circulates in plasma as a heterodimer (d... (9670020)